Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ascendx Partners with Anwerina to Reach European Markets - Orthopedic Design & Technology

Ascendx Partners with Anwerina to Reach European Markets

The company already has a presence in France.

Following the recent U.S. Food and Drug Administration (FDA) clearance of its product Acu-Cut, Ascendx Spine is expanding its reach in Europe by partnering with Switzerland-based Anwerina AG. Ascendx, based in Winter Park, Fla., is looking at Austria, Germany and Switzerland as potential new markets for its spine products. The company recently partnered with Spinaxis for distribution in France.

Acu-Cut, which was approved by the FDA in late February, is a uni-pedicular vertebral augmentation system designed to create a cavity for precise bone cement placement. This procedure goes hand in hand with placement of spinal balloons in the standard treatment procedure for vertebral compression fractures (VCFs), the balloon kyphoplasty. Anwerina has had market success with VCF treatments in past years, according to Dr. Christoph C. Karl, Ph.D., Chairman and CEO of the company.

Anwerina is a pharmaceutical and medical device company focused on the surgical treatment of traumatic conditions of the musculoskeletal system.

Ascendx specializes in orthopedic devices for the spine and trauma markets, with a specific focus on VCF treatments.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters